Medicina
Facultad
Universidad de Murcia
Murcia, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Murcia (164)
2024
-
Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022) (Clinical and Translational Oncology, (2023), 25, 9, (2647-2664), 10.1007/s12094-023-03215-4)
Clinical and Translational Oncology
-
Identifying COPD patients with poor health status and low exercise tolerance through the five-repetition sit-to-stand test and modified Medical Research Council Dyspnea Score
European Journal of Internal Medicine, Vol. 125, pp. 51-56
-
Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group
Clinical and Translational Oncology
-
N-terminal pro-B-type natriuretic peptide post-discharge monitoring in the management of patients with heart failure and preserved ejection fraction – a randomized trial: The NICE study
European Journal of Heart Failure, Vol. 26, Núm. 4, pp. 776-784
-
PICO questions and DELPHI methodology for improving the management of patients with acute hepatic porphyria
Revista Clinica Espanola, Vol. 224, Núm. 5, pp. 272-280
-
Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma
Blood, Vol. 143, Núm. 7, pp. 597-603
-
Prognostic Implications of Blood Immune-Cell Composition in Metastatic Castration-Resistant Prostate Cancer
Cancers, Vol. 16, Núm. 14
-
Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection
Haematologica, Vol. 109, Núm. 6, pp. 1909-1917
-
Relationship between academic climate and burnout in Spanish medical schools
Educacion Medica, Vol. 25, Núm. 6
-
Selinexor, daratumumab, bortezomib and dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma: results of the phase II, non-randomized, multicenter GEM-SELIBORDARA study
Haematologica, Vol. 109, Núm. 7, pp. 2219-2228
-
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression
Blood cancer journal, Vol. 14, Núm. 1, pp. 74
-
Thrombosis in breast cancer patients on cyclin-dependent kinase inhibitors: Survival impact and predictive factors - A study by the cancer and thrombosis group of the spanish society of medical oncology (SEOM)
European Journal of Internal Medicine
-
Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational study
The Lancet Haematology, Vol. 11, Núm. 8, pp. e606-e616
2023
-
A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide
Prostate, Vol. 83, Núm. 4, pp. 376-384
-
Academic climate and psychopathological symptomatology in Spanish medical students
BMC Medical Education, Vol. 23, Núm. 1
-
Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment
American Journal of Cardiology, Vol. 203, pp. 122-127
-
Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years
GeroScience, Vol. 45, Núm. 1, pp. 543-553
-
Analytical Tool for Quality Control of Irrigation Waters via a Potentiometric Electronic Tongue
Chemosensors, Vol. 11, Núm. 7
-
Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction
Journal of Clinical Medicine, Vol. 12, Núm. 8
-
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 3019-3031